Spiriva Respimat Inhaler 2.5 mcg 60 dose


The Spiriva Respimat Inhaler is a handheld device that delivers medication as a fine mist, suitable for inhalation. Unlike the HandiHaler, which delivers dry powder, the Respimat inhaler uses a liquid cartridge and does not require the capsules used with the HandiHaler. It is specifically designed for daily administration and is not recommended to relieve sudden breathing difficulties immediately.



Spiriva Respimat Inhaler contains the active ingredient tiotropium bromide, a long-acting bronchodilator classified as an anticholinergic medication. It is formulated to manage and treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, and to control asthma symptoms in adults and children over the age of 6. The medication aids in relaxing the muscles around the airways, improving airflow and making breathing easier. Regular use is aimed at enhancing the quality of life by reducing respiratory symptoms.

Additional information



● Daily maintenance therapy for bronchospasm associated with COPD.
● Maintenance treatment of asthma in individuals aged 6 and above.

Administration Guidelines:


● The recommended dose of Spiriva Respimat is two inhalations once daily. Consistency in the timing of the administered dose is crucial for optimal results.

Method of Administration:

● It should be administered via the Spiriva Respimat inhaler after proper training on the inhalation technique to ensure the medication is effectively delivered to the lungs.

Dosage Form:

● Respimat Inhaler: This inhaler utilizes a spring-powered mechanism to deliver a specific amount of tiotropium in a fine mist, inhaled into the lungs.

Safety Preclusions

Pregnancy and Breastfeeding:

● Potential risks and benefits should be evaluated before using Spiriva Respimat during pregnancy.

● It has not been established whether tiotropium passes into breast milk; hence, caution is recommended when administered to breastfeeding women.

Long-term Use:

● Spiriva Respimat is intended for sustained treatment. Regular monitoring by a healthcare provider is advised to check for continued effectiveness and the emergence of adverse reactions.

Drug Interactions:

● Anticholinergic drugs may have additive effects when used in conjunction with Spiriva Respimat. Patients must disclose all medications being taken to a healthcare professional.

Side Effects

● Common side effects can include a dry mouth, cough, and headache. There is also a possibility of experiencing upper respiratory infections and sinusitis.

Serious Side Effects:

● Allergic reactions presenting as rashes, hives, or breathing difficulties
● Eye problems like pain, vision changes, or halos, could indicate acute narrow-angle glaucoma.


● Store the Spiriva Respimat inhaler at room temperature. Keep it away from excessive heat and light. Ensure that the inhaler is closed securely.

Special Precautions

● Individuals with pre-existing conditions such as narrow-angle glaucoma and urinary retention should use Spiriva Respimat with caution and under close medical observation.

● Inhalation is the only intended route of administration for the medication; ingestion of the solution is incorrect and could be dangerous.


● Overdosing on Spiriva Respimat can lead to symptoms like dry mouth, eye pain, or increased heart rate. If an overdose is suspected, immediate medical intervention is required. Anticholinergic overdose symptoms are a medical emergency and require prompt treatment.


There are no reviews yet.

Be the first to review “Spiriva Respimat Inhaler 2.5 mcg 60 dose”

Your email address will not be published. Required fields are marked *